These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32334055)

  • 1. Anticancer therapies associated with secondary cutaneous malignancies: A review of the literature.
    Deutsch A; Balagula Y; McLellan BN
    J Am Acad Dermatol; 2020 Nov; 83(5):1425-1433. PubMed ID: 32334055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple secondary cutaneous tumours following electron beam radiotherapy for cutaneous malignancies of the scalp.
    Wolfe CM; Green WH; Hatfield HK; Shakar TJ; Baniahmad O; Cognetta AB
    Australas J Dermatol; 2012 Aug; 53(3):233-8. PubMed ID: 22724681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emergence of supportive oncodermatology: the study of dermatologic adverse events to cancer therapies.
    Balagula Y; Rosen ST; Lacouture ME
    J Am Acad Dermatol; 2011 Sep; 65(3):624-635. PubMed ID: 21777992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy-associated solid tumors.
    Travis LB
    Acta Oncol; 2002; 41(4):323-33. PubMed ID: 12234023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatologic toxicities of targeted antineoplastic agents and immune checkpoint inhibitor therapy in pediatric patients: A systematic review.
    Liu LY; Teng JMC; Spunt SL; Strelo JL; Kwong BY; Zaba LC
    Pediatr Blood Cancer; 2021 Dec; 68(12):e29346. PubMed ID: 34569142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatologic Adverse Events of Systemic Anticancer Therapies: Cytotoxic Chemotherapy, Targeted Therapy, and Immunotherapy.
    Deutsch A; Leboeuf NR; Lacouture ME; McLellan BN
    Am Soc Clin Oncol Educ Book; 2020 May; 40():485-500. PubMed ID: 32421446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary neoplasms in 5-year survivors of cancer in childhood: results of the Childhood Cancer Survivor Study].
    Beck JD
    Strahlenther Onkol; 2002 Mar; 178(3):167-8. PubMed ID: 11962196
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous Adverse Events of Targeted Therapies for Hematolymphoid Malignancies.
    Ransohoff JD; Kwong BY
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):834-851. PubMed ID: 28918995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
    Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
    Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous marginal zone lymphoma as a complication of radiation therapy: Case report and review.
    Breton AL; Poulalhon N; Balme B; Thomas L; Dalle S
    Dermatol Online J; 2010 Dec; 16(12):6. PubMed ID: 21199632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic radiation and the potential risk of second malignancies.
    Kamran SC; Berrington de Gonzalez A; Ng A; Haas-Kogan D; Viswanathan AN
    Cancer; 2016 Jun; 122(12):1809-21. PubMed ID: 26950597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary tumors after X-ray radiation therapy of the skin.
    Sminia P; Carl UM
    Arch Dermatol; 1995 Sep; 131(9):1088-9. PubMed ID: 7661618
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutaneous toxicities of antineoplastic agents: data from a large cohort of Greek patients.
    Nikolaou V; Voudouri D; Tsironis G; Charpidou A; Stamoulis G; Triantafyllopoulou I; Panoutsopoulou I; Xidakis E; Bamias A; Samantas E; Aravantinos G; Gogas H; Rigopoulos D; Syrigos K; Stratigos A
    Support Care Cancer; 2019 Dec; 27(12):4535-4542. PubMed ID: 30919155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential risks and benefits of radiation therapy as adjuvant treatment in patients with low-risk carcinoma of the mammary gland: taking cutaneous postradiation angiosarcoma as an opportunity for a critical appraisal of postoperative radiotherapy.
    Bernier J
    Ann Oncol; 2007 Apr; 18(4):619-21. PubMed ID: 17351257
    [No Abstract]   [Full Text] [Related]  

  • 15. Cutaneous Complications of Targeted Melanoma Therapy.
    de Golian E; Kwong BY; Swetter SM; Pugliese SB
    Curr Treat Options Oncol; 2016 Nov; 17(11):57. PubMed ID: 27645330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of melanoma following adulthood cancer: a case-control study.
    Dupuy A; Shamsaldin A; Quiniou E; Paoletti C; Labbé M; Avril MF; Lefkopoulos D; de Vathaire F
    Eur J Cancer; 2005 Dec; 41(18):2904-10. PubMed ID: 16243516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dermatologic adverse events of the new targeted anticancer therapies used in oncodermatology].
    Sibaud V; Delord JP; Chevreau C; Gangloff D; Garrido-Stowhas I
    Ann Chir Plast Esthet; 2012 Apr; 57(2):106-13. PubMed ID: 22425393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronous angiosarcoma, melanoma and morphea of the breast skin 14 years after radiotherapy for mammary carcinoma.
    de Giorgi V; Santi R; Grazzini M; Papi F; Gori A; Rossari S; Massi D; Lotti T
    Acta Derm Venereol; 2010 May; 90(3):283-6. PubMed ID: 20526547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous reactions to pediatric cancer treatment part II: Targeted therapy.
    Carlberg VM; Davies OMT; Brandling-Bennett HA; Leary SES; Huang JT; Coughlin CC; Gupta D
    Pediatr Dermatol; 2021 Jan; 38(1):18-30. PubMed ID: 33378085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Secondary malignant neoplasms following postoperative radiotherapy of breast cancer].
    Reitzig P; Czekalla A; Czekalla M
    Z Arztl Fortbild (Jena); 1992 Apr; 86(7-8):419-20. PubMed ID: 1615725
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.